Abstract
Many of the therapeutic goals of diabetes care, such as lifestyle changes for weight management and medication adherence, are also effective for diabetes prevention. The diabetes educator can play a critical role in identifying and educating individuals at high risk for type 2 diabetes. Early detection of high-risk status provides an opportunity for early intervention and long-term health promotion. The diabetes educator is in a unique position to facilitate and support individual’s efforts in implementing a diabetes prevention plan. The Diabetes Prevention Program – a national clinical trial sponsored by the National Institute of Diabetes, Digestive, and Kidney Diseases – showed that a lifestyle intervention with the goal of moderate weight loss (5–10 of body weight) and increasing physical activity (150 minutes of moderate intensity exercise per week) are recommended for prevention of type 2 diabetes. The study also showed that pharmacologic treatment with metformin has also shown a degree of effectiveness for diabetes prevention in certain individuals. Prevention of type 2 diabetes can help alleviate the human and economic toll of this chronic disease which has become a worldwide epidemic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.
CDC: National Diabetes Fact Sheet, 2005 available from http://www.cdc.gov/diabetes/ pubs/factsheet05.htm Accessed 29 October 2007.
American Diabetes Association: Direct and Indirect Costs of Diabetes in the United States On the internet at: http://www.diabetes.org/diabetes-statistics/cost-of-diabetes-in-us.jsp Accessed 29 October 2007.
The Diabetes Prevention Program Research Group: Within-trial cost effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 26:2518–2523,2003.
Tapp RJ, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, Shaw JE for the Aus Diab study group. Association between impaired glucose metabolism and quality of life: results from the Austrailan Diabetes Obesity and Lifestyle Study. Diabetes Res Clin Pract 2006;74:154–161.
Banegas JR, Lopez-Garcia E, Graciani A, et al.: Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly. Eur J Cardiovac Prev Rehabil 2007;14(3):456–462.
The Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the DaQing IGT and Diabetes Study. Diabetes Care 1997;20:537–544.
Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1342–1350.
Chiasson JL, Josse RG, Gomis R, Hanefetd M, Karasik A, Laakso M, the STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NODDM randomized trial. Lancet 2002;359:2072–2077.
Gerstein HC, Yusuf S, Borch J, Pogue J, Sheridan P, Dinccag N, Hanefetd M, Hoogwerf B, Lasskso M, Mohan V, Shaw J, Zinman B, Holman RR: Dream (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368:1096–1100.
Wylie G, Hungin AP, Neely J: Impaired glucose tolerance: qualitative and quantitative study of general practitioner’s knowledge and perceptions. BMJ 2002;324:1190.
Nathan D, Davidson M, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B: Impaired fasting glucose and impaired glucose tolerance. Diabetes Care 2007;30:753–759.
Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chtson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius: Diabetes Care 1999;22:399–402.
Nichols GA, Hillier TA, Brown JB:Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care 2007;30:228–233.
Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575–581.
National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, Md: National Heart, Lung and Blood Institute: 1998.
American Diabetes Association: Standard of care for diabetes-2006.Diabetes Care 2006;29 (Suppl.):S4–S42.
Metzger BE, Buchanan TA, Coustan DR, et al.:Summary and recommendations of the Fifth International Workshop-conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30:S251–S260.
Lawler DA, Keen S, Neal RD. Can general practitioners influence the nation’s health through a population approach to provision of lifestyle advice?. Br J Gen Pract 2000;50:455–459.
Pill R, Stott NCH, rollnick SR, Rees M. A randomized controlled trial of an intervention designed to improve the care given in general practice to type 2 diabetic patients: patient outcomes and professional ability to change behavior. Fam Pract 1998;15:229–35.
The Diabetes Prevention Program Research Group: The Diabetes Prevention Program description of lifestyle intervention. Diabetes Care 2002;25:2163–2171.
American College of Sports Medicine, ACSM’s Guidelines for Exercise Testing and Prescription, 7$^th$ ed, Baltimore, MD: Lippincott Williams & Wilkins, 2006.
Diabetes Prevention Program Study Repository. For further information regarding the Diabetes Prevention Program Lifestyle session, materials, learning objectives. On the internet: www.bsc.gwu.edu/dpp/manuals.htmlvdoc Accessed 29 October 2007.
National Diabetes Education Program. For further information regarding the “Small Steps. Big Rewards. Prevent type 2 Diabetes” materials On the internet: http//www.ndep.nih.gov Accessed 29 October 2007.
The Diabetes Prevention Program Research Group: Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res 2004;12:1426–1434.
West DS, DiLillo V, Bursac Z, et al.: Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007;30:1081–1087.
Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD: Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol 2001;69:717–721.
Marrero D, Ackermann R: Providing long-term support for lifestyle changes: a key to success in diabetes prevention. Diabetes Spectrum 2007;20:205–209.
The Diabetes Prevention Program Research Group: Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care 2005;28:888–894.
Buchanan TA, Xiang AH, Peters Rk, Kjos Sl, Maroquin A, Goico J, et al. Preservation of pancreatic beta-call function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women. Diabetes 2002;51:2796–803.
Walker E, Molitch M, Kramer MK, Kahn S, Yong M, Edelstein S, et al. Adherence to preventive medications predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29:1997–2002.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Duffy, H., Brown-Friday, J.O., Walker, E.A. (2009). Prevention: Educating Those at Risk for Diabetes. In: Weinger, K., Carver, C.A. (eds) Educating Your Patient with Diabetes. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-60327-208-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-60327-208-7_19
Publisher Name: Humana Press
Print ISBN: 978-1-60327-207-0
Online ISBN: 978-1-60327-208-7
eBook Packages: MedicineMedicine (R0)